Tryptophan scanning mutagenesis in TM4 of the GABAA receptor α1 subunit: implications for modulation by inhaled anesthetics and ion channel structure

[1]  F. R. Salemme,et al.  Structural and functional diversity in 4-α-helical proteins , 1980, Nature.

[2]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[3]  P. Seeburg,et al.  Transient expression shows ligand gating and allosteric potentiation of GABAA receptor subunits. , 1988, Science.

[4]  Robert A. Pearce,et al.  Effect of Volatile Anesthetics on Synaptic Transmission in the Rat Hippocampus , 1989 .

[5]  J. Nickoloff,et al.  Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. , 1992, Analytical biochemistry.

[6]  N. Harrison,et al.  Positive modulation of human gamma-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane. , 1993, Molecular pharmacology.

[7]  M. P. Blanton,et al.  Identifying the lipid-protein interface of the Torpedo nicotinic acetylcholine receptor: secondary structure implications. , 1994, Biochemistry.

[8]  W. R. Lieb,et al.  Molecular and cellular mechanisms of general anaesthesia , 1994, Nature.

[9]  N. Unwin.  Acetylcholine receptor channel imaged in the open state , 1995, Nature.

[10]  S. Tamamizu,et al.  Tryptophan substitutions at the lipid-exposed transmembrane segment M4 of Torpedo californica acetylcholine receptor govern channel gating. , 1996, Biochemistry.

[11]  N. Harrison,et al.  Chimeric GABAA/Glycine Receptors: Expression and Barbiturate Pharmacology , 1996, Neuropharmacology.

[12]  M. Akabas,et al.  Identification of channel-lining residues in the M2 membrane-spanning segment of the GABA(A) receptor alpha1 subunit , 1996, The Journal of general physiology.

[13]  R. Mckernan,et al.  Which GABAA-receptor subtypes really occur in the brain? , 1996, Trends in Neurosciences.

[14]  D. S. Weiss,et al.  Stoichiometry of a Recombinant GABAA Receptor , 1996, The Journal of Neuroscience.

[15]  R. Harris,et al.  Inhibition of rho1 receptor GABAergic currents by alcohols and volatile anesthetics. , 1996, The Journal of pharmacology and experimental therapeutics.

[16]  R. Harris,et al.  Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors , 1997, Nature.

[17]  M. McNamee,et al.  Mutations in the M4 Domain of the Torpedo californica Nicotinic Acetylcholine Receptor Alter Channel Opening and Closing , 1997, The Journal of Membrane Biology.

[18]  F. Barrantes,et al.  Mutations at lipid-exposed residues of the acetylcholine receptor affect its gating kinetics. , 1998, Molecular pharmacology.

[19]  A. Jenkins,et al.  Agonist gating and isoflurane potentiation in the human gamma-aminobutyric acid type A receptor determined by the volume of a second transmembrane domain residue. , 1999, Molecular pharmacology.

[20]  S. Tamamizu,et al.  Alteration in Ion Channel Function of Mouse Nicotinic Acetylcholine Receptor by Mutations in the M4 Transmembrane Domain , 1999, The Journal of Membrane Biology.

[21]  R. Mckernan,et al.  Stoichiometry of a Ligand-gated Ion Channel Determined by Fluorescence Energy Transfer* , 1999, The Journal of Biological Chemistry.

[22]  N. Harrison,et al.  General anaesthetic actions on ligand-gated ion channels , 1999, Cellular and Molecular Life Sciences CMLS.

[23]  Cynthia Czajkowski,et al.  Mapping the Agonist Binding Site of the GABAAReceptor: Evidence for a β-Strand , 1999, The Journal of Neuroscience.

[24]  P. Whiting.  The GABA-A receptor gene family: new targets for therapeutic intervention , 1999, Neurochemistry International.

[25]  M. MacIver,et al.  Membrane and Synaptic Actions of Halothane on Rat Hippocampal Pyramidal Neurons and Inhibitory Interneurons , 2000, The Journal of Neuroscience.

[26]  M. P. Blanton,et al.  Topography of Nicotinic Acetylcholine Receptor Membrane-embedded Domains* , 2000, The Journal of Biological Chemistry.

[27]  M. Cascio,et al.  Coupled Proteolytic and Mass Spectrometry Studies Indicate a Novel Topology for the Glycine Receptor* , 2000, The Journal of Biological Chemistry.

[28]  N. Harrison,et al.  The actions of ether, alcohol and alkane general anaesthetics on GABAA and glycine receptors and the effects of TM2 and TM3 mutations , 2000, British journal of pharmacology.

[29]  J. Trudell,et al.  Specific binding sites for alcohols and anesthetics on ligand-gated ion channels. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. A. Harris,et al.  Tryptophan scanning mutagenesis in TM2 of the GABAA receptor α subunit: effects on channel gating and regulation by ethanol , 2000, British journal of pharmacology.

[31]  F. Barrantes,et al.  Nicotinic Receptor Fourth Transmembrane Domain: Hydrogen Bonding by Conserved Threonine Contributes to Channel Gating Kinetics , 2000 .

[32]  S. Tamamizu,et al.  Functional effects of periodic tryptophan substitutions in the alpha M4 transmembrane domain of the Torpedo californica nicotinic acetylcholine receptor. , 2000, Biochemistry.

[33]  M. P. Blanton,et al.  Structure of the Pore-forming Transmembrane Domain of a Ligand-gated Ion Channel* , 2001, The Journal of Biological Chemistry.

[34]  E. Bertaccini,et al.  Anesthetics and ion channels: molecular models and sites of action. , 2001, Annual review of pharmacology and toxicology.

[35]  H. Faulkner,et al.  Evidence for a Common Binding Cavity for Three General Anesthetics within the GABAA Receptor , 2001, The Journal of Neuroscience.

[36]  E. Bertaccini,et al.  Molecular modeling of ligand-gated ion channels: progress and challenges. , 2001, International review of neurobiology.

[37]  E. Bertaccini,et al.  Predicting the transmembrane secondary structure of ligand-gated ion channels. , 2002, Protein engineering.

[38]  A. Jenkins,et al.  Volatile anesthetic actions on the GABAA receptors: contrasting effects of α1(S270) and β2(N265) point mutations , 2002, Neuropharmacology.